Neuromuscular Control in Individuals Following ACL-Reconstruction
Completed · Not applicable
Conditions studied: Anterior Cruciate Ligament Injuries, Quadriceps Muscle Atrophy
In brief
The purpose of this study is to investigate the neurophysiological contributors to muscle function following ACL Reconstruction and the influence of motor control biofeedback exercise on measures of muscle function. The research team hypothesizes that the application of motor biofeedback will increase cortical excitability of the quadriceps compared to the passive movement of the knee. This is a single session cross-over intervention study with a 1-week washout period between treatment arms.
Key facts
- Study ID
- NCT04495075
- Run by
- University of Virginia
- People needed
- 10
- Starts
- 2019-03-01
- Expected to finish
- 2020-03-01
- Last updated by the study team
- 2020-07-31
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- • Ages 18-45
- At the time point of return to play progression following ACL Reconstruction
- Physically active individuals based on current ACSM guidelines of 30 minutes of moderate-intensity daily physical activity three days a week)
You may not qualify if…
- Subjects who are known to be pregnant (self-reported)
- Subjects diagnosed with malignancy
- Subjects with serious infection near the lower limb
- Subjects with known muscular abnormalities
- History of cardiopulmonary disorder
- Subjects with a previous history of stroke
- History of neurological or psychiatric disorders including poorly controlled migraine headaches, seizure disorder, history or immediate family history of seizures and/or epilepsy
- Subjects with any type of neuropathy (numbness and tingling)
- Subjects with a clinical diagnosis of multiple sclerosis (MS) or Parkinson's Disease
- Implanted biomedical device (active or inactive implants (including device leads), including deep brain stimulators, cochlear implants, and vagus nerve stimulators)
- History of skull fracture
- Subjects who have any metal implants anywhere in their head, neck or shoulders
- Patients taking any medications, which may influence cortical excitability, which could influence neurophysiologic measures) and affect objective clinical data (e.g. antispastics, anxiolytics, hypnotics, ant-epileptics)
- Subjects who are prescribed medications which may influence cortical excitability, which could influence neurophysiologic measures) and affect objective clinical data (e.g. antispastics, anxiolytics, hypnotics, ant-epileptics), will not be able to remain in the study.
- Unable to provide consent.
Where it is running
- University of Virginia — Charlottesville, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.